Pneumococcal serology in children's respiratory infections

M Korppi1, M Leinonen, O Ruuskanen

  • 1Pediatric Research Center, Tampere University and University Hospital, FinMed-3, 33014 Tampere, Finland. matti.korppi@uta.fi

Insights

Serological tests for Streptococcus pneumoniae infections show promise in children, indirectly validating their sensitivity and specificity for diagnosing pneumonia. However, these complex methods are currently limited to research settings.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Streptococcus pneumoniae is a key cause of respiratory tract infections.
  • Serological methods for detecting pneumococcal infections are validated in adults but less so in children due to low bacteremia rates.
  • A gold standard for diagnosing pneumococcal infections in children is lacking, necessitating validation of existing serological approaches.

Purpose of the Study:

  • To provide indirect evidence for the sensitivity and specificity of pneumococcal serology in children.
  • To assess the utility of serological assays in various pediatric respiratory conditions.
  • To evaluate the influence of study setting and assay type on diagnostic accuracy.

Main Methods:

  • Analysis of serological evidence of pneumococcal infection in children with confirmed pneumonia, viral wheezy bronchitis, and viral upper respiratory infections.
  • Comparison of results from antibody assays and combined antibody and immune complex assays.
  • Assessment of serological responses in relation to nasopharyngeal carriage and acquisition of new serotypes.

Main Results:

  • Serological evidence of pneumococcal infection ranged from 27%–38% in pneumonia, 7%–8% in viral wheezy bronchitis, and <1%–5% in viral upper respiratory infections.
  • Combined antibody and immune complex assays identified higher rates (32%–37% in inpatients, 27%–28% in outpatients) compared to antibody assays alone (10%–18%).
  • While nasopharyngeal carriage had minimal impact, new serotype acquisition could induce significant antibody production.

Conclusions:

  • Indirect evidence suggests pneumococcal antibody and immune complex assays are sufficiently sensitive and specific for detecting pneumococcal infections in children.
  • Serological findings are influenced by the study venue and the specific test panel used.
  • Current serological methods are too complex for routine clinical practice and remain primarily research tools.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...